Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Benign opsoclonus in preterm infants.

Yair Morad1, Oren G Benyamini, Isaac Avni

  • 1Department of Ophthalmology, Assaf Harofeh Medical Center, Tel Aviv University, Zrifin 73000, Israel.

Pediatric Neurology
|October 7, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluating the effect of a new myopia control spectacle lens among children in Israel: 24-month results.

Eye (London, England)·2026
Same author

Changes in Axial Length and Refraction After Gradual Versus Prompt Cessation of Atropine 0.01% Treatment for Myopia Management.

Current eye research·2025
Same author

Non-absorbable sutures use in bilateral lateral rectus recession reduces the rate of overcorrection in exotropia.

Strabismus·2025
Same author

Three-Muscle Surgery for Large- and Medium-Angle Intermittent Exotropia.

Journal of pediatric ophthalmology and strabismus·2025
Same author

[COMBINED TREATMENT OF RAPIDLY INCREASING MYOPIA: A CASE SERIES].

Harefuah·2025
Same author

Lateral rectus superior plication using non-absorbable sutures for adult onset esotropia.

Strabismus·2025
Same journal

Corrigendum to Temporary Pacemaker in a Pediatric Guillain-Barré Case With Life-Threatening Bradyarrhythmia Pediatr Neurol 177 (2026) 109-110. doi: 10.1016/j.pediatrneurol.2026.01.015.

Pediatric neurology·2026
Same journal

Clinical Symptoms in Late Infantile and Juvenile Onset Neuronal Ceroid Lipofuscinosis Type 7 (CLN7 Disease).

Pediatric neurology·2026
Same journal

Examining Epilepsy in Angelman Syndrome: Insights From Caregiver-Reported Data in the Linking Angelman and Dup15q Data for Expanded Research Database.

Pediatric neurology·2026
Same journal

Impact of Postpandemic Pediatric Infection Rebound on Febrile Seizures: A Nationwide Cohort Study, 2013-2023.

Pediatric neurology·2026
Same journal

The Hidden Cost of Developmental and Epileptic Encephalopathy in Australia: Caregiver Quality of Life, Sleep, Depression, and Workforce Participation.

Pediatric neurology·2026
Same journal

A Novel Neonatal Brain Injury Score for Infants With Congenital Diaphragmatic Hernia.

Pediatric neurology·2026
See all related articles

Opsoclonus, an eye movement disorder, was found in 0.6% of preterm infants. This condition often resolves on its own by six months, suggesting it can be benign in premature babies.

Area of Science:

  • Pediatric Ophthalmology
  • Neonatology
  • Neuroscience

Background:

  • Opsoclonus is a rare, involuntary eye movement disorder.
  • It is often associated with neuroblastoma and neurological abnormalities.
  • However, opsoclonus has also been observed in healthy infants.

Observation:

  • This study prospectively investigated opsoclonus prevalence in preterm infants (gestation < 33 weeks or birth weight < 1500 gm).
  • 528 preterm infants were screened for opsoclonus.
  • Opsoclonus was identified in 3 infants (0.6%), who were neurologically intact.

Findings:

  • The three infants with opsoclonus showed no other physical or neurological complications.
  • One infant had retinopathy of prematurity that resolved with treatment.

Related Experiment Videos

  • Opsoclonus resolved spontaneously by 6 months of age in all affected infants.

    • Implications:

    • Opsoclonus may be a benign, self-limiting condition in preterm infants.
    • Despite potential benignity, associated severe illnesses necessitate diagnostic procedures.
    • Continued careful follow-up is recommended until the opsoclonus resolves spontaneously.